The estimated Net Worth of Brian Larkin is at least $597 Thousand dollars as of 4 October 2021. Mr. Larkin owns over 2,601 units of Dynatronics stock worth over $30,940 and over the last 12 years he sold DYNT stock worth over $565,884. In addition, he makes $0 as Independent Director at Dynatronics.
Sign up
Mr. Larkin DYNT stock SEC Form 4 insiders trading
Brian has made over 16 trades of the Dynatronics stock since 2013, according to the Form 4 filled with the SEC. Most recently he bought 3,734 units of DYNT stock worth $597 on 4 January 2022.
The largest trade he's ever made was buying 40,000 units of Dynatronics stock on 30 November 2017 worth over $100,000. On average, Brian trades about 2,657 units every 61 days since 2013. As of 4 October 2021 he still owns at least 193,372 units of Dynatronics stock.
You can see the complete history of Mr. Larkin stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Brian Larkin biography
Brian M. Larkin serves as Independent Director of the Company. Mr. Larkin is President and CEO of SP Industries, Inc., a privately held provider of laboratory equipment, supplies and specialty glassware and aseptic processing drug manufacturing solutions headquartered in Pennsylvania. From May 2017 to February 2018, he served as the Vice President and General Manager of the Diabetes Care business at Becton Dickinson (NYSE: BDX). From May 2015 to May 2017, he served as Senior Vice President and General Manager for the LifeCell Regenerative Medicine business at Acelity L.P., Inc. Prior to joining Acelity, Mr. Larkin was Corporate Vice President of Integra Lifesciences Holdings Corporation, where he served as President of the Global Spine and Orthobiologics businesses, and Head of Strategic Development. His responsibilities included executive oversight and leadership of Integra’s worldwide Spine and Orthobiologics businesses, in addition to executive oversight of several of Integra’s corporate functions, including corporate marketing and strategic planning. Mr. Larkin joined Integra in January 2000, as a Regional Sales Manager. He was promoted to National Sales Manager in 2003, Vice President, North American Sales in 2005, and President of Integra’s Neurosurgery business in 2007. In 2010, he was appointed President, Global Spine & Orthobiologics, and Head of Strategic Development. Mr. Larkin has over 25 years of sales, marketing, and executive management experience in the medical technology industry. Prior to joining Integra, he was the National Sales Manager for Connell Neurosurgical. Mr. Larkin received a B.S. degree in Chemistry from the University of Richmond and completed the Advanced Management Program at Harvard Business School.
How old is Brian Larkin?
Brian Larkin is 50, he's been the Independent Director of Dynatronics since 2015. There are 7 older and 6 younger executives at Dynatronics. The oldest executive at Dynatronics Corp. is R. Scott Ward, 63, who is the Independent Director.
What's Brian Larkin's mailing address?
Brian's mailing address filed with the SEC is 526 E. EVERGREEN AVE, , WYNDMOOR, PA, 19038.
Insiders trading at Dynatronics
Over the last 21 years, insiders at Dynatronics have traded over $277,594 worth of Dynatronics stock and bought 3,744,819 units worth $3,168,592 . The most active insiders traders include Stuart Essig, Erin S. Enright, and Ventures 1 Lp Provco. On average, Dynatronics executives and independent directors trade stock every 54 days with the average trade being worth of $5,399. The most recent stock trade was executed by R Scott Ward on 4 January 2022, trading 5,000 units of DYNT stock currently worth $800.
What does Dynatronics do?
dynatronics manufactures, markets, and distributes advanced-technology medical devices, treatment tables, and rehabilitation - acute-care - sport medicine - chiropractic - massage equipment as well as over 8,000 products and supplies. in addition, dynatronics has the most experienced and knowledgeable sales force in the industry. with more than 60 sales representatives and 150 active distributors located throughout the country, we are able to provide immediate service. dynatronics has built a solid reputation over the past 31 years for competitive pricing, excellent customer service, and unmatched clinical support. our field support team handles everything from equipment set-up to in-service training.
What does Dynatronics's logo look like?
Complete history of Mr. Larkin stock trades at Dynatronics and Integra Lifesciences Corp
Dynatronics executives and stock owners
Dynatronics executives and other stock owners filed with the SEC include:
-
Brian D. Baker,
Director & Consultant -
John A. Krier,
CEO, Pres & Director -
Norman Roegner III,
Chief Financial Officer -
Brian Baker,
Director -
Erin Enright,
Independent Chairman of the Board -
Norman Roegner,
Chief Financial Officer -
John Krier,
Chief Executive Officer, Director -
Ed Staten,
Senior Director of Sales Operations -
Jennifer Keeler,
General Counsel -
R. Scott Ward,
Independent Director -
Brian Larkin,
Independent Director -
Scott Klosterman,
Independent Director -
David Holtz,
Independent Director -
Skyler Black,
Principal Accounting Officer -
James Ogilvie,
Vice President - Corporate Development -
Mark A. Crockett,
Consultant -
Sarah Rome-Mealman,
VP of Marketing -
Jason C. Anderson,
Chief Information Officer -
Robert J Cardon,
Secretary/Treasurer -
David Alma Wirthlin,
Chief Financial Officer -
Ventures 1 Lp Provco,
10% owner -
Larry K Beardall,
Exec. Vice President -
Stuart Essig,
10% owner -
Jako Christopher Richard Von,
Chief Executive Officer -
Thomas J Gephart,
Vice President of Sales -
Nancy Cronin,
-
Kelvyn H Jr Cullimore,
Chief Executive Officer -
Howard L Edwards,
Director -
Joseph H Barton,
Director -
Val John Christensen,
Director -
Terry M Atkinson,
Chief Financial Officer -
Kelvyn H Cullimore,
Chairman of the Board -
E Keith Hansen,
Director -
James E Woods,
-
Ronald J Hatch,
VP Prod/R&D -
Corp Dynatronics,
-
Andrew Hulett,
Director